A diagnosis of "low-grade glioma" often brings a confusing mix of relief and worry. It usually means the tumor is slower-growing than a high-grade tumor — but it does not mean "nothing to worry about," and the path forward can look different from what people expect.
Low-grade gliomas generally refer to grade 1 and grade 2 tumors. Grade 1 tumors, such as pilocytic astrocytoma (common in children), are often well-contained and can sometimes be cured with surgery alone. Grade 2 diffuse gliomas are slower-growing but tend to infiltrate surrounding brain tissue, which is why they often cannot be completely removed, and over time some can transform into higher grades.
For many adults with low-grade glioma, the most useful mental model is chronic disease management rather than a single battle. Care often unfolds over years and may include a combination of:
- Surgery to remove as much as safely possible and to confirm the molecular diagnosis.
- Active surveillance — regular MRI scans to watch a stable tumor closely (covered in its own article on watch-and-wait).
- Radiation and chemotherapy when the tumor grows, causes symptoms, or has features suggesting it needs treatment.
- Targeted therapy, including vorasidenib for certain IDH-mutant grade 2 gliomas after surgery, and BRAF-targeted drugs in certain pediatric low-grade gliomas.
Living with a low-grade glioma also means living with uncertainty, and that is genuinely hard. Many people feel pressure to "do something" when their team recommends watching and waiting. It can help to remember that monitoring is an active, evidence-based choice — not passivity — and that the goal is to intervene at the right time, not necessarily the earliest possible moment. Seizure control, quality of life, work, and mental health are all part of the care plan, not afterthoughts.